Pazdur To Oncology Drug Developers: Step Back, Slow Down – And Find The Right Dose

 
• By Kate Rawson
  
Cancer cells on scientific background.3d illustration
Waiting to address dosing issues post approval will not be an option in the future. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D